Scinai Immunotherapeutics... (SCNI)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
3.43
-0.02 (-0.58%)
At close: Jan 15, 2025, 1:32 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
PE Ratio | -0.37 | -0.96 | -4.04 | -22.47 | -2.4 | -1.33 | -2.79 | -4.75 | -3.99 | -3.41 | -2.59 | -2.17 | -2.23 | -1.79 | -2.89 | -2.63 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -0.52 | -3.17 | 33.78 | -6.86 | -4.03 | -3.73 | 1.72 | 1.70 | 1.21 | 1.59 | 0.87 | 0.88 | 0.72 | 0.56 | 0.40 | 1.06 |
P/FCF Ratio | -0.24 | -0.69 | -4.38 | -1.27 | -3.1 | -1.44 | -6.63 | -4.51 | -3.95 | -3.48 | -4.72 | -2.77 | -1.39 | -1.72 | -3.81 | n/a |
P/OCF Ratio | -0.25 | -0.77 | -4.47 | -1.38 | -3.4 | -2.04 | -9.61 | -4.52 | -3.96 | -3.49 | -4.94 | -2.89 | -1.78 | -1.94 | -3.94 | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | -4.5 | -12.24 | 29.52 | -4.6 | -2.02 | -3.02 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 3.06 | 6.15 | 7.30 | 0.17 | 3.86 | 3.53 | 10.94 | 19.01 | 21.74 | 7.01 | 11.43 | 17.34 | 12.29 | 10.07 | 16.25 | 15.56 |
Current Ratio | 3.06 | 6.15 | 7.30 | 0.17 | 3.86 | 3.53 | 10.94 | 19.01 | 21.74 | 7.01 | 11.43 | 17.34 | 12.29 | 10.07 | 16.25 | 15.56 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | 30.65K | -2.19 | 3.45 | 6.74 | -5.3 | -5.45 | 52.32K | -30.89K | -371.72K | -1.24K | 1.55K | n/a | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | 1.42 | 3.29 | -8.36 | 0.31 | 1.68 | 2.81 | -0.61 | -0.36 | -0.3 | -0.47 | -0.34 | -0.41 | -0.32 | -0.31 | -0.14 | -0.4 |
Return on Assets (ROA) | -0.37 | -0.21 | -0.26 | -0.08 | -0.94 | -0.83 | -0.42 | -0.31 | -0.25 | -0.42 | -0.31 | -0.39 | -0.3 | -0.29 | -0.13 | -0.38 |
Return on Capital (ROIC) | -0.62 | -0.45 | -0.37 | -1.01 | -0.81 | -0.92 | -0.32 | -0.41 | -0.29 | -0.49 | -0.32 | -0.4 | -0.34 | -0.32 | -0.14 | -0.43 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |